Hear from the experts in the field of early-stage breast cancer on the performance and utility of the Prosigna® breast cancer prognostic gene signature in this webinar. From current to emerging treatment options, the speaker panel will discuss different biomarker strategies that support shared decision-making for the management of hormone-receptor positive (HR+) patients.
Genomic Profiling and the Future of Early Breast Cancer Care
29th September 2020
Download the speakers’ presentations here:
Join our mailing list
To receive the EMJ updates straight to your inbox free of charge, please click the button below.Join Now